Inventor · disambiguated record
Padmanabh P. Bhatt
Also filed as: BHATT PADMANABH · BHATT PADMANABH P · BHATT PADMANABH PRAVINCHANDRA
53 granted patents·35 pending applications·774 citations·filing 1995–2025
99Inventor score
Top patents by PatentIndex Score
88 records- 0197US8598191B2Controlled release compositions of gamma-hydroxybutyrateLIANG LIKAN·Filed 2012·Granted Dec 3, 2013·76 cites·15 claims
- 0297US8193211B2Controlled release compositions of gamma-hydroxybutyrateLIANG LIKAN·Filed 2005·Granted Jun 5, 2012·87 cites·30 claims
- 0396US8747897B2Osmotic drug delivery systemKIDANE ARGAW·Filed 2006·Granted Jun 10, 2014·57 cites·60 claims
- 0495US8617600B2Modified release preparations containing oxcarbazepine and derivatives thereofBHATT PADMANABH P·Filed 2012·Granted Dec 31, 2013·25 cites·22 claims
- 0595US6368626B1Controlled delivery of active agentsALZA CORP·Filed 1999·Granted Apr 9, 2002·131 cites·11 claims
- 0694US7763635B2Once daily dosage forms of trospiumSUPERMUS PHARMACEUTICALS INC·Filed 2007·Granted Jul 27, 2010·20 cites·6 claims
- 0793US7781448B2Once daily dosage forms of trospiumSUPERNUS PHARMACEUTICALS INC·Filed 2007·Granted Aug 24, 2010·6 cites·44 claims
- 0893US7759359B2Method of treating bladder dysfunction with once-a-day trospium salt formulationSUPERNUS PHARMACEUTICALS INC·Filed 2007·Granted Jul 20, 2010·6 cites·9 claims
- 0992US8298580B2Sustained-release formulations of topiramateLIANG LIKAN·Filed 2010·Granted Oct 30, 2012·12 cites·31 claims
- 1092US7410978B2Once daily dosage forms of trospiumSUPERNUS PHARMACEUTICALS INC·Filed 2004·Granted Aug 12, 2008·22 cites·37 claims
- 1191US7611728B2Osmotic delivery of therapeutic compounds by solubility enhancementSUPERNUS PHARMACEUTICALS INC·Filed 2003·Granted Nov 3, 2009·75 cites·17 claims
- 1291US2025367208A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1390US7781449B2Trospium chloride treatment methodSUPERNUS PHARMACEUTICALS INC·Filed 2007·Granted Aug 24, 2010·8 cites·26 claims
- 1489US9662338B2Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted May 30, 2017·5 cites·14 claims
- 1589US8748472B2Stabilized formulations of CNS compoundsCHANG RONG-KUN·Filed 2011·Granted Jun 10, 2014·11 cites·44 claims
- 1688US10265319B2Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2017·Granted Apr 23, 2019·4 cites·20 claims
- 1788US9358204B2Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2013·Granted Jun 7, 2016·7 cites·13 claims
- 1888US9119792B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2014·Granted Sep 1, 2015·5 cites·20 claims
- 1987US7910131B2Method of treating seizures using modified release formulations of oxcarbazepineSUPERNUS PHARMACEUTICALS INC·Filed 2008·Granted Mar 22, 2011·4 cites·24 claims
- 2087US7722898B2Modified-release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2007·Granted May 25, 2010·5 cites·20 claims
- 2187US6630165B2Methods for providing effective reboxetine therapy with once-a-day dosingALZA CORP·Filed 2002·Granted Oct 7, 2003·27 cites·3 claims
- 2287US2023381191A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2386US2023081113A1Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2485US9603853B2Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·3 cites·14 claims
- 2585US8663683B2Sustained-release formulations of topiramateLIANG LIKAN·Filed 2012·Granted Mar 4, 2014·4 cites·24 claims
- 2684US11077114B2Stabilized formulations of CNS compoundsSUPERNUS PHARMACEUTICALS INC·Filed 2018·Granted Aug 3, 2021·1 cites·28 claims
- 2784US2023255892A1Osmotic drug delivery systemSUPERNUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2883US8017149B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2008·Granted Sep 13, 2011·2 cites·22 claims
- 2983US6855334B2Controlled delivery of active agentsALTA CORP·Filed 2001·Granted Feb 15, 2005·21 cites·7 claims
- 3083US6387403B1Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosingALZA CORP·Filed 2000·Granted May 14, 2002·18 cites·21 claims
- 3182US10220042B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2017·Granted Mar 5, 2019·1 cites·27 claims
- 3282US9403783B2Methods for producing viloxazine salts and novel polymorphs thereofLIANG LIKAN·Filed 2011·Granted Aug 2, 2016·6 cites·7 claims
- 3382US9119791B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2014·Granted Sep 1, 2015·2 cites·24 claims
- 3482US2025222004A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3582US2025228859A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3680US11896599B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2019·Granted Feb 13, 2024·0 cites·20 claims
- 3780US11166960B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2021·Granted Nov 9, 2021·0 cites·6 claims
- 3879US9855278B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·1 cites·21 claims
- 3978US9370525B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2015·Granted Jun 21, 2016·1 cites·21 claims
- 4078US9351975B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2015·Granted May 31, 2016·1 cites·20 claims
- 4178US8821930B2Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2013·Granted Sep 2, 2014·1 cites·20 claims
- 4278US2023210823A1Formulations of mazindolSUPERNUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4377US10149853B2Stabilized formulations of CNS compoundsSUPERNUS PHARMACEUTICALS INC·Filed 2014·Granted Dec 11, 2018·2 cites·22 claims
- 4477US8298576B2Sustained-release formulations of topiramateLIANG LIKAN·Filed 2007·Granted Oct 30, 2012·1 cites·30 claims
- 4577US2021308142A9Modified release preparations containing oxcarbazepine and derivatives thereofSUPERNUS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4676US9393203B2Osmotic drug delivery systemSUPERNUS PHARMACEUTICALS INC·Filed 2015·Granted Jul 19, 2016·1 cites·23 claims
- 4776US8211464B2Modified release preparations containing oxcarbazepine and derivatives thereofBHATT PADMANABH P·Filed 2011·Granted Jul 3, 2012·1 cites·26 claims
- 4876US2022024885A1Methods for producing viloxazine salts and novel polymorphs thereofSUPERNUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4975US8889191B2Sustained-release formulations of topiramateLIANG LIKAN·Filed 2010·Granted Nov 18, 2014·1 cites·24 claims
- 5073US10005743B2Methods for producing viloxazine salts and novel polymorphs thereofSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted Jun 26, 2018·1 cites·12 claims
Showing the top 50 of 88 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Padmanabh P. Bhatt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →